# Noninvasive CA Monitoring Validation and Autonomic Modulation in Aneurysmal Subarachnoid Hemorrhage

Study · id `cardio:ct-nct07577739` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07577739](<https://clinicaltrials.gov/study/NCT07577739>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT07577739

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 300 participants.

## Technical summary

Registry record NCT07577739. Non-randomized; no masking; primary purpose basic science. Start 2027-07 (anticipated); primary completion 2029-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose basic science
- Phase: Not applicable
- Enrolled: 300 participants (planned count; ClinicalTrials.gov record NCT07577739, source copy `cardio:ctgov-nct07577739-2026-10-16`, retrieved 2026-10-31)
- Planned start: 2027-07 (anticipated) (ClinicalTrials.gov record NCT07577739, source copy `cardio:ctgov-nct07577739-2026-10-16`, retrieved 2026-10-31)
- Primary completion: 2029-06 (anticipated) (ClinicalTrials.gov record NCT07577739, source copy `cardio:ctgov-nct07577739-2026-10-16`, retrieved 2026-10-31)
- Completion: 2030-06 (anticipated) (ClinicalTrials.gov record NCT07577739, source copy `cardio:ctgov-nct07577739-2026-10-16`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT07577739, source copy `cardio:ctgov-nct07577739-2026-10-16`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07577739-2026-10-16`, retrieved 2026-10-31)

## The registry's words

- Brief title: Noninvasive CA Monitoring Validation and Autonomic Modulation in Aneurysmal Subarachnoid Hemorrhage
- Condition: Subarachnoid Hemorrhage, Aneurysmal
- Condition: Delayed Cerebral Ischemia
- Condition: Cerebral Vasospasm
- Condition: Autonomic Nervous System Diseases
- Intervention (Procedure): Right-Sided Cervical Sympathetic Block at C6
- Intervention (Device): Transcutaneous Auricular Vagal Nerve Stimulation (taVNS)
- Lead sponsor: University of Texas Southwestern Medical Center
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Subarachnoid hemorrhage (`cardio:subarachnoid-hemorrhage`)
- Registry lists this organization as the lead sponsor: University of Texas Southwestern Medical Center (`cardio:org-university-of-texas-southwestern-medical-center`)

## Provenance

Content hash: 6d4a7673ad3c86058dd66b171c473b921694b4abbea292a8b7b68f8223fd2c97
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
